These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1657 related items for PubMed ID: 18046223

  • 1. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M, Ramezani A, Bijanzadeh B, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Tabatabaei H, Peyman GA.
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
    Soheilian M, Ramezani A, Obudi A, Bijanzadeh B, Salehipour M, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Peyman GA.
    Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
    [Abstract] [Full Text] [Related]

  • 3. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
    Soheilian M, Garfami KH, Ramezani A, Yaseri M, Peyman GA.
    Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244
    [Abstract] [Full Text] [Related]

  • 4. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.
    Lim JW, Lee HK, Shin MC.
    Ophthalmologica; 2012 Feb; 227(2):100-6. PubMed ID: 21997197
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA, Diab MM, Abo-Elenin M.
    Retina; 2010 Feb; 30(10):1638-45. PubMed ID: 20838357
    [Abstract] [Full Text] [Related]

  • 6. Initial macular thickness and response to treatment in diabetic macular edema.
    Soheilian M, Ramezani A, Yaseri M, Mirdehghan SA, Obudi A, Bijanzadeh B.
    Retina; 2011 Sep; 31(8):1564-73. PubMed ID: 21451442
    [Abstract] [Full Text] [Related]

  • 7. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.
    Faghihi H, Roohipoor R, Mohammadi SF, Hojat-Jalali K, Mirshahi A, Lashay A, Piri N, Faghihi Sh.
    Eur J Ophthalmol; 2008 Sep; 18(6):941-8. PubMed ID: 18988166
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
    Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Liu DT, Li KK, Li PS, Shanmugam MP.
    Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months.
    Arevalo JF, Lasave AF, Wu L, Diaz-Llopis M, Gallego-Pinazo R, Alezzandrini AA, Berrocal MH, Pan-American Collaborative Retina Study Group (PACORES).
    Retina; 2013 Feb; 33(2):403-13. PubMed ID: 23222389
    [Abstract] [Full Text] [Related]

  • 11. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema.
    Solaiman KA, Diab MM, Dabour SA.
    Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema.
    Synek S, Vojniković B.
    Coll Antropol; 2010 Apr; 34 Suppl 2():99-103. PubMed ID: 21305729
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
    Sonoda Y, Arimura N, Shimura M, Sakamoto T.
    Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.
    Retina; 2006 Feb; 26(9):999-1005. PubMed ID: 17151486
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T, Longo A, Reibaldi A.
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.
    Riazi-Esfahani M, Riazi-Esfahani H, Ahmadraji A, Karkhaneh R, Mahmoudi A, Roohipoor R, Ghasemi F, Yaseri M.
    Int Ophthalmol; 2018 Apr; 38(2):585-598. PubMed ID: 28349504
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A, Shenazandi H, Lashay A, Faghihi H, Alimahmoudi A, Dianat S.
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 83.